Yuhua Weng
- Pharmaceutical Science top 1%
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 30
- Advanced biosensing and bioanalysis techniques 29
- Extracellular vesicles in disease 5
- Biomaterials top 2%
- Cancer Research top 5%
- MicroRNA in disease regulation 5
- Immunology top 10%
-
- Plasmonic and Surface Plasmon Research 11
- Nanoplatforms for cancer theranostics 10
-
- Gold and Silver Nanoparticles Synthesis and Applications 6
-
- SARS-CoV-2 and COVID-19 Research 5
- Journals
- Journal of the American Chemical Society (2 papers)Advanced Materials (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesNepal
In The Last Decade
Yuhua Weng
60 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Pharmaceutical Science 328
- Molecular Biology 2.8k
- Biomaterials 482
- Cancer Research 452
- Immunology 416
Countries citing papers authored by Yuhua Weng
This map shows the geographic impact of Yuhua Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhua Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhua Weng more than expected).
Fields of papers citing papers by Yuhua Weng
This network shows the impact of papers produced by Yuhua Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhua Weng. The network helps show where Yuhua Weng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuhua Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 32 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 18 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 22 | |
| 8 | 2022 | 76 | |
| 9 | 2022 | 68 | |
| 10 | 2022 | 81 | |
| 11 | 2021 | 58 | |
| 12 | 2020 | 52 | |
| 13 | The challenge and prospect of mRNA therapeutics landscapebreakdown → | 2020 | 310 |
| 14 | 2020 | 71 | |
| 15 | 2019 | 82 | |
| 16 | 2014 | 19 | |
| 17 | 2013 | 25 | |
| 18 | 2013 | 101 | |
| 19 | The Discovery and Revelation of Tricarboxylic Acid Cycle | 2012 | 1 |
| 20 | 2012 | 18 |
About Yuhua Weng
Yuhua Weng is a scholar working on Molecular Biology, Aging and Biomedical Engineering, having authored 65 papers that have together received 3.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (30 papers), Advanced biosensing and bioanalysis techniques (29 papers), Plasmonic and Surface Plasmon Research (11 papers), Nanoplatforms for cancer theranostics (10 papers), Gold and Silver Nanoparticles Synthesis and Applications (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), MicroRNA in disease regulation (5 papers) and Extracellular vesicles in disease (5 papers). The work is most often cited by research in Pharmaceutical Science (328 citations), Molecular Biology (2.8k citations) and Biomaterials (482 citations). Yuhua Weng has collaborated with scholars based in China, United States and Nepal. Frequent co-authors include Yuanyu Huang, Bo Hu, Xing‐Jie Liang, Ling Peng, Yongxiang Zhao, Liping Zhong, Jun Zhang, Haihua Xiao, Shuai Guo and Tongren Yang. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.